Drug search by name

Canagliflozin and Metformin Extended-Release Tablets and Hyperkalemia

Result of checking the interaction of drug Canagliflozin and Metformin Extended-Release Tablets and disease Hyperkalemia for safety when used together.

Check result:

Canagliflozin and Metformin Extended-Release Tablets <> Hyperkalemia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Canagliflozin can cause hyperkalemia and it should be used with caution in patients predisposed to this condition due to the use of certain medications or other medical conditions. Serum potassium levels should be monitored periodically after initiating canagliflozin, specially in patients with impaired renal function.

Canagliflozin and Metformin Extended-Release Tablets

Generic Name: canagliflozin / metformin

Brand Name: Invokamet, Invokamet XR

Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin

What is Canagliflozin and Metformin Extended-Release Tablets?